AKTX

Companies
NASDAQ
Akari Therapeutics Plc ADR
Health Care
Price Chart
Overview

About AKTX

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).

Market Cap
$26.2M
Volume
12.0K
Avg. Volume
30.0K
P/E Ratio
-0.3822353
Dividend Yield
0.00%
Employees
8.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
0.81
Moderate Correlation
Volatility
High (1.00)
Relative to market
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for AKTX.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, AKTX shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$26.2M
Volume12.0K
P/E Ratio-0.38
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
September 27, 2022
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how AKTX fits into your investment strategy and portfolio diversification.

Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025